Page last updated: 2024-11-12
florasulam
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
florasulam: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11700495 |
CHEMBL ID | 3185236 |
CHEBI ID | 82009 |
SCHEMBL ID | 116614 |
MeSH ID | M0369927 |
Synonyms (42)
Synonym |
---|
145701-23-1 |
florasulam |
primus |
00a64zx8nb , |
n-(2,6-difluorophenyl)-5-methoxy-8-fluoro-(1,2,4)-triazolo-(1,5c)-pyrimidine-2-sulfonamide |
kantor |
hsdb 7941 |
unii-00a64zx8nb |
florasulam [iso] |
C18850 |
tox21_302433 |
cas-145701-23-1 |
dtxcid5024340 |
NCGC00255762-01 |
dtxsid7044340 , |
n-(2,6-difluorophenyl)-8-fluoro-5-methoxy-[1,2,4]triazolo[1,5-c]pyrimidine-2-sulfonamide |
FT-0631173 |
AKOS015901201 |
SCHEMBL116614 |
2',6',8-trifluoro-5-methoxy(1,2,4)triazolo(1,5-c)pyrimidine-2-sulfonanilide |
n-(2,6-difluorophenyl)-8-fluoro-5-methoxy(1,2,4)triazolo(1,5-c)pyrimidine-2-sulfonamide |
(1,2,4)triazolo(1,5-c)pyrimidine-2-sulfonamide, n-(2,6-difluorophenyl)-8-fluoro-5-methoxy- |
nikos |
florasulam [mi] |
CHEBI:82009 , |
QZXATCCPQKOEIH-UHFFFAOYSA-N |
n-(2,6-difluorophenyl)-8-fluoro-5-methoxy[1,2,4]triazolo[1,5-c]pyrimidine-2-sulfonamide |
c12h8f3n5o3s |
CHEMBL3185236 |
A1-01909 |
[1,2,4]triazolo[1,5-c]pyrimidine-2-sulfonamide, n-(2,6-difluorophenyl)-8-fluoro-5-methoxy- |
florasulam, pestanal(r), analytical standard |
florasulam 10 microg/ml in acetonitrile |
J-008140 |
DS-6608 |
DB15316 |
Q22807578 |
kantor; primus; primus sc |
AMY12231 |
A884585 |
CS-0013914 |
[1,2,4]triazolo[1,5-c]pyrimidine-2- sulfonamide, n-(2,6-difluorophenyl)-8-fluoro-5-methoxy- |
Research Excerpts
Overview
Florasulam is a triazolopyrimidine sulfonanilide post-emergence broadleaf herbicide for use in wheat.
Excerpt | Reference | Relevance |
---|---|---|
"Florasulam is a triazolopyrimidine sulfonanilide post-emergence broadleaf herbicide for use in wheat (Triticum aestivum L.). " | ( Uptake, translocation and metabolism of the herbicide florasulam in wheat and broadleaf weeds. deBoer, GJ; Ehr, RJ; Thornburgh, S, 2006) | 2.02 |
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
" Accordingly, in this study, we investigated the toxic effect of florasulam on the freshwater microalga Chlorella vulgaris and sought to identify the underlying mechanisms." | ( Direct toxicity of the herbicide florasulam against Chlorella vulgaris: An integrated physiological and metabolomic analysis. Deng, J; Jiang, X; Jiao, Q; Li, X; Liu, X; Mu, Y; Yao, X; Zhang, F; Zhao, X, 2022) | 1.24 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" The seed was subjected to glasshouse tests where dose-response studies were conducted and ED80 values generated." | ( Establishment of the baseline sensitivity and monitoring response of Papaver rhoeas populations to florasulam. Paterson, EA; Shenton, ZL; Straszewski, AE, 2002) | 0.53 |
" These results will contribute to establishing the scientific basis of the dosage of florasulam and tribenuron-methyl for use in wheat field ecosystems." | ( Dissipation kinetics and residues of florasulam and tribenuron-methyl in wheat ecosystem. Dong, B; Hu, J; Qian, W, 2015) | 0.91 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
Class | Description |
---|---|
sulfonamide | An amide of a sulfonic acid RS(=O)2NR'2. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein Targets (1)
Potency Measurements
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
AR protein | Homo sapiens (human) | Potency | 39.1181 | 0.0002 | 21.2231 | 8,912.5098 | AID743036 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (22)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (36.36) | 29.6817 |
2010's | 10 (45.45) | 24.3611 |
2020's | 4 (18.18) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 30.65
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (30.65) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (4.55%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 21 (95.45%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |